UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
For the month of November 2022
 
 
Commission File Number:  001-39034
 
 
BELLUS HEALTH INC.
 
(Name of registrant)

275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
 Canada
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
 
☐   Form 20-F
☒   Form 40-F
  
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
  
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
BELLUS Health Inc.
 
  
 
  
     
Date: November 14, 2022
By:
 /s/ Ramzi Benamar
  
   
Name:   Ramzi Benamar
  
   
Title:     Chief Financial Officer
  

 

 
Form 6-K Exhibit Index
 
Exhibit
Number
  
Document Description
 
 
 
 

BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more BELLUS Health Charts.
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more BELLUS Health Charts.